Your browser doesn't support javascript.
loading
Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
Matta, Benjamin M; Reichenbach, Dawn K; Zhang, Xiaoli; Mathews, Lisa; Koehn, Brent H; Dwyer, Gaelen K; Lott, Jeremy M; Uhl, Franziska M; Pfeifer, Dietmar; Feser, Colby J; Smith, Michelle J; Liu, Quan; Zeiser, Robert; Blazar, Bruce R; Turnquist, Heth R.
Afiliación
  • Matta BM; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;
  • Reichenbach DK; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
  • Zhang X; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; Xiangya School of Medicine, Central South University, Changsha, Hunan, China;
  • Mathews L; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;
  • Koehn BH; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
  • Dwyer GK; Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA;
  • Lott JM; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA;
  • Uhl FM; Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University Medical Center Freiburg, Albert-Ludwigs University, Freiburg, Germany;
  • Pfeifer D; Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University Medical Center Freiburg, Albert-Ludwigs University, Freiburg, Germany;
  • Feser CJ; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
  • Smith MJ; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
  • Liu Q; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Cardiovascular Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China;
  • Zeiser R; Department of Hematology and Oncology, University Medical Center, Albert-Ludwigs University, Freiburg, Germany; and.
  • Blazar BR; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
  • Turnquist HR; Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Blood ; 128(3): 427-39, 2016 07 21.
Article en En | MEDLINE | ID: mdl-27222477

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre de Sangre Periférica / Interleucina-33 / Proteína 1 Similar al Receptor de Interleucina-1 / Enfermedad Injerto contra Huésped / Activación de Macrófagos / Macrófagos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre de Sangre Periférica / Interleucina-33 / Proteína 1 Similar al Receptor de Interleucina-1 / Enfermedad Injerto contra Huésped / Activación de Macrófagos / Macrófagos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article